<DOC>
	<DOCNO>NCT01044251</DOCNO>
	<brief_summary>This study analyze effectiveness medication call Frovatriptan , context medication overuse headache ( MOH ) . MOH headache develop pain-killers take frequently . The treatment stop overuse pain-killers , sometimes worsen headache first get well . We test Frovatriptan placebo see help patient transition avoid worsen headache occur . We also see Frovatriptan help way , maintain patient free medication overuse .</brief_summary>
	<brief_title>Frovatriptan Transitional Therapy Medication Overuse Headache</brief_title>
	<detailed_description>A single-centre , randomize , placebo-controlled trial propose assess Frovatriptan transitional therapy patient diagnosed medication overuse headache . Currently , proven transitional therapy help patient get detoxification process . Frovatriptan test transitional therapy past . This study compare Frovatriptan , take 10 day transitional period , placebo . The primary outcome study mean headache intensity 10 day transitional period Frovatriptan group compare placebo group . A number secondary exploratory outcome also determine data collection occur 1 , 2 , 3 month period . The duration study participant 3 month , ask keep detailed headache diary time . Ten day baseline headache diary also perform patient enter study .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders , Secondary</mesh_term>
	<mesh_term>Frovatriptan</mesh_term>
	<criteria>MOH diagnose IHS criterion Diagnosis migraine ( without aura ) past IHS criterion If patient baseline diary , prospective diary 10day period do confirm medication overuse study entry . Patients age 18 65 year . Normal neurological examination . Patient willing able ( term capacity ) sign inform consent . Patient able understand complete study protocol , include completion headache diary . Patient stable medical condition . Headache meeting IHS criterion MOH . Presence hemiplegic , basilar , ophthalmoplegic migraine migrainous infarction . Findings history , neurological exam , neuroimaging suggestive secondary cause headache . Postwhiplash posttraumatic headache . Contraindications triptans ( heart disease , peripheral vascular disease uncontrolled hypertension ) previous serious side effects/intolerance . Major psychiatric condition ( major depression , bipolar disorder , schizophrenia , addiction ) , either diagnose physician positive standard clinic assessment tool ( e.g . BDI questionnaire ) . Major medical condition treatment may interfere patient 's ability participate study , dementia , advance terminal cancer , chemotherapy , etc . Patient pregnant , breastfeeding , expect conceive within time period study . Pregnancy determine use urine test . Women childbearing potential use reliable method contraception . Patient recent user illicit/recreational drug plan use illicit drug study time period . Patient recent history alcohol abuse dependence , plan abuse alcohol study duration . Patient unlikely comply study protocol , keep diary appointment , fix telephone address . Patient enrol another study trial may interfere participation result study . Patients great 30 % data miss ten day baseline diary data collection . Patients mean headache intensity less 3 ( pain scale 0 10 , 0=no pain 10=pain bad possible ) 10day baseline period . Patients ongoing Botox treatment receive Botox last 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Medication overuse headache</keyword>
	<keyword>Rebound headache</keyword>
	<keyword>Analgesic overuse headache</keyword>
	<keyword>Transitional therapy</keyword>
	<keyword>Frovatriptan</keyword>
	<keyword>Migraine</keyword>
</DOC>